Skip to main content
Venmax Drugs And Pharmaceuticals Ltd logo

Venmax Drugs And Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · 531015 ISIN · INE154G01022 BSE.NS Manufacturing
Open in API
Filings indexed 4 across all filing types
Latest filing 2026-05-15 Capital/Financing Update
Country IN India
Listing BSE.NS 531015

About Venmax Drugs And Pharmaceuticals Ltd

https://www.venmaxdrugs.com

Venmax Drugs And Pharmaceuticals Ltd specializes in the development, manufacturing, and distribution of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company’s product portfolio spans multiple therapeutic categories, including anti-infectives, gastrointestinal agents, analgesics, and cardiovascular medications. It operates manufacturing facilities designed to meet various regulatory requirements, focusing on the production of generic drugs and providing contract manufacturing services. The organization serves a broad client base by delivering a range of dosage forms such as tablets, capsules, and liquids. Venmax focuses on maintaining quality standards across its supply chain to ensure the efficacy and safety of its medicinal products for diverse healthcare needs.

Recent filings

Filing Released Lang Actions
Statement of Deviation & variation for the Quarter and Year ended March 31, 2026.
Capital/Financing Update Classification · 82% confidence The document is a regulatory filing under SEBI LODR Regulation 32 providing a statement on deviation/variation in the use of proceeds from a preferential issue (capital raise). It is an update on financing activities and use of fund proceeds rather than an actual financial report, annual report, or notice of dividend. It directly relates to the company’s capital-raising and utilization of funds. Therefore, it falls under Capital/Financing Update (CAP).
2026-05-15 English
Newspaper Advertisement of the Audited Financial results for the Quarter and Year ended March 31, 2026.
Report Publication Announcement Classification · 90% confidence The document is a submission to BSE under Regulation 47 of SEBI LODR notifying the publication of the company’s newspaper advertisement of audited financial results for the quarter and year ended March 31, 2026. It does not itself contain the full financial statements, but is an announcement that the advertisement (and full report) has been published and is available on the website. Under the “menu vs. meal” rule, this is a Report Publication Announcement, not the actual interim report or earnings release.
2026-05-15 English
Audited Financial Results for the Quarter and Year ended March 31 , 2026
Interim / Quarterly Report Classification · 92% confidence The document is a full set of audited standalone financial results filed under SEBI Regulation 33, including the Statement of Financial Results for the quarter and year ended 31 March 2026, Balance Sheet, Cash Flow Statement, Notes to Accounts, and the Independent Auditor’s Report. It contains substantive financial data and is not merely an announcement or certification. This aligns with the definition of an Interim / Quarterly Report (comprehensive financial report for a period shorter than a fiscal year, here also including the year‐end audited figures). FY 2026
2026-05-14 English
Audited Financial Results for the Quarter and Year ended March 31, 2026
Interim / Quarterly Report Classification · 75% confidence The document is a comprehensive, detailed set of audited standalone financial results for the quarter and year ended 31 March 2026, including Statement of Financial Results, Statement of Assets & Liabilities, Cash Flow, Notes and an Independent Auditor’s Report under SEBI Regulation 33. It is more than a simple earnings release (ER) or announcement (RPA) and not a full Annual Report (10-K) with narrative/disclosures, but it is a full set of period-end financial statements, consistent with an Interim / Quarterly Report filing. Therefore, it best fits the IR category. FY 2026
2026-05-14 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.